Welcome to the e-CCO Library Archive!
Y-ECCO Literature Review: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense
ECCO News Issue 03/2014
Kris Nys
Y-ECCO Literature Review: Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response
ECCO News Issue 01/2013
Gwenny Fuhler
Y-ECCO Literature Review: Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis
ECCO News Issue 02/2016
Lieke Spekhorst
Y-ECCO Literature Review: Ciclosporin versus infliximab in patients with severe Ulcerative Colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
ECCO News Issue 01/2013
Joana Torres
Y-ECCO Literature Review: Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in Ulcerative Colitis
ECCO News Issue 01/2014
Jeff Chang
Y-ECCO Literature Review: Comparative effectiveness of immunosuppressant and biologics for inducing and maintaining remission in Crohn’s Disease: A network meta-analysis
ECCO News Issue 04/2014
Piotr Eder
Y-ECCO Literature Review: Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy
ECCO News Issue 01/2015
David Drobne
Y-ECCO Literature Review: Crohn’s Disease management after intestinal resection: a randomised trial
ECCO News Issue 03/2015
Constantinos Parisinos
Y-ECCO Literature Review: Cyclosporine or infl iximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study
ECCO News Issue 01/2012
Dirk P. Van Asseldonk
Y-ECCO Literature Review: Early administration of azathioprine versus conventional management of Crohn’s Disease: A randomised controlled trial
ECCO News Issue 03/2013
Anja Schirbel
Y-ECCO Literature Review: Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
ECCO News Issue 04/2011
Johanne Brooks
Y-ECCO Literature Review: East-West gradient in the incidence of Inflammatory Bowel Disease in Europe: the ECCO-EpiCom inception cohort
ECCO News Issue 04/2013
Daniel Trabulo
Y-ECCO Literature Review: Etrolizumab as induction therapy for ulcerative colitis: A randomised, controlled, phase 2 trial
ECCO News Issue 03/2014
Triana Lobatón
Y-ECCO Literature Review: Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn’s Disease
ECCO News Issue 02/2015
Sandrine Coumes
Y-ECCO Literature Review: Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn’s-like murine ileitis
ECCO News Issue 01/2012
Sander van der Marel
Y-ECCO Literature Review: Gene-microbiota interactions contribute to the pathogenesis of Inflammatory Bowel Disease
ECCO News Issue 03/2016
Floris Imhann
Y-ECCO Literature Review: Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells
ECCO News Issue 03/2015
Timon Adolph
Y-ECCO Literature Review: Identification of patients with variants in TPMT and dose reduction reduces hematologic events during thiopurine treatment of Inflammatory Bowel Disease
ECCO News Issue 04/2015
Vasile Balaban
Y-ECCO Literature Review: IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient.
ECCO News Issue 02/2011
Christine Breynaert
Y-ECCO Literature Review: Incidence and phenotype of Inflammatory Bowel Disease based on results From the Asia-Pacific Crohn’s and Colitis Epidemiology Study
ECCO News Issue 03/2013
Valérie Pittet